Stocks recovered dramatically from session lows yesterday, on higher volume. All five major indices closed lower on the session but well off their worst levels of the day. The S&P 500 contained losses to 0.5% after being as much as 1.2% down on the day. Read more…
NASDAQ:IBB
Stocks finished modestly higher on Tuesday, on mixed trade. All of the major exchanges ended the day higher, with the Nasdaq and S&P MidCap 400 leading the advance. Both indices closed up by 0.6%. The S&P 500 added 0.5%, while the small-cap Russell 2000 Read more…
NASDAQ:IBB, NYSE:DUST
Equities moved higher on Thursday on higher trade. The small-cap Russell 2000 had the best performance yesterday, as it tacked on an impressive 1.3%. The Dow Jones Industrial Average added 1.2%, while the S&P 500 improved by 1.1%. The S&P MidCap 400 Read more…
NASDAQ:IBB
Stocks posted solid gains on Friday but trade was light. All of the major indices closed in the black. The small-cap Russell 2000 demonstrated the most strength as it climbed 1.2% on the day. The Nasdaq posted a 1.0% gain, while the S&P MidCap 400 tacked on 0.9%. Read more…
NASDAQ:IBB, NYSE:XLP
Don Miller: Innovations in biotechnology are evolving at the speed of light. In fact, astonishing advancements in biotech have transformed the way we practice medicine. Leading-edge biotech products and breakthroughs are literally saving thousands of lives every day. Read more…
NASDAQ:IBB, NYSE:XBI, PBE
Michael Johnston: Despite some rather significant bumps along the road in 2011, many asset classes are now well into positive territory on a one year trailing basis as January draws to a close, riding high thanks to a strong finish to last year and start to 2012. Included on that list are a number of Read more…
NASDAQ:BIB, NASDAQ:IBB, NYSE:LBND, NYSE:TYD, NYSE:UGL
In trading on Monday, the iShares Nasdaq Biotechnology (NASDAQ:IBB) is outperforming other ETFs, up about 4.78% on the day. Also up on the day are the Read more…
NASDAQ:IBB, NYSE:BABS, NYSE:CRBI, NYSE:EMFN, NYSE:LGEM, NYSE:XBI
Eric Dutram: The past week was, again, extremely choppy as European rumors took center stage, leaving investors fixated on events coming out of Germany and France. While some progress was definitely made in the negotiations, this week’s summit could play a key role in determining the long term Read more…
AMEX:HHH, NASDAQ:IBB, NYSE:GDX
In trading on Thursday, the C-Tracks Citi Volatility Index TR ETN (NYSE:CVOL) is outperforming other ETFs, up about 35.28% on the day. Also up on the day are the Read more…
NASDAQ:IBB, NYSE:CVOL, NYSE:FBT, NYSE:VIXY, NYSE:VXX, NYSE:XBI
Ron Rowland: Like many of you, I’m a Baby Boomer. Now I find myself north of 50 and the prospect of getting “old” isn’t very attractive. What does this have to do with investing and ETFs? Plenty! Read more…
NASDAQ:BIB, NASDAQ:BIS, NASDAQ:IBB, NYSE:FBT, NYSE:XBI, PBE
Stocks were obliterated on Wednesday as volume surged. The markets sold off sharply at the open, rallied modestly at the 11:00 am reversal period and spent the remainder of the day in a downward spiral. All five major indices opened at the high and closed near the dead lows of the day. Read more…
NASDAQ:IBB, NYSE:IHI, NYSE:PPH, NYSE:XRT
Stocks rallied sharply on Tuesday and closed near session highs. All of the major indices added more than 1.5%. The Nasdaq (NASDAQ:QQQ) put in an impressive performance led largely by the recent good fortune of Apple Inc. (NASDAQ:AAPL) and Google (NASDAQ:GOOG). The tech rich index led Read more…
NASDAQ:IBB, PBJ, QQQ
David Fry: Our goal in this profile is to help investors wade through the many competing ETF offerings available. Using our long experience as an ETF publication, and nearly 40 years in the investment business, we can help select those ETFs that matter and may or may not be repetitive. Read more…
NASDAQ:IBB, NYSE:FBT, NYSE:FXH, NYSE:IHF, NYSE:IYH, NYSE:PPH, NYSE:XBI, NYSE:XLV
Alex Strashny: Recommended funds. Our main recommendation this week is real estate (NYSE:IYR). Its expected return jumped last week as it gained +4.46% in 5 days on slightly higher volume. However, its risk is high and has increased slightly. Because of the high risk in IYR, some Read more…
NASDAQ:IBB, NYSE:EWM, NYSE:IYR, NYSE:SMH, NYSE:XLE, NYSE:XLU, PJP
Alex Strashny: Recommended funds: Biotech (NYSE:IBB) remains our primary recommendation this week. With the +1.68% rise and slightly higher volume over the past week, the expected return is definitely positive and slightly higher. IBB’s risk has decreased over the past week Read more…
NASDAQ:IBB, NYSE:EWJ, NYSE:EWM, NYSE:GLD, NYSE:IYR, NYSE:SPY, NYSE:XLE, PJP
Most Comments